TY - JOUR AU - Aletaha, D. AU - Smolen, J. S. PY - 2003 DA - 2003// TI - DMARD use in early rheumatoid arthritis. Lessons from observations in patients with established disease JO - Clin Exp Rheumatol VL - 21 ID - Aletaha2003 ER - TY - JOUR AU - Aletaha, D. AU - Stamm, T. AU - Kapral, T. AU - Eberl, G. AU - Grisar, J. AU - Machold, K. P. AU - Smolen, J. S. PY - 2003 DA - 2003// TI - Survival and effectiveness of leflunomide compared with methotrexate and sulfasalazine in rheumatoid arthritis: a matched observational study JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.10.944 DO - 10.1136/ard.62.10.944 ID - Aletaha2003 ER - TY - JOUR AU - Andersen, P. A. AU - West, S. G. AU - O'Dell, J. R. AU - Via, C. S. AU - Claypool, R. G. AU - Kotzin, B. L. PY - 1985 DA - 1985// TI - Weekly pulse methotrexate in rheumatoid arthritis. Clinical and immunologic effects in a randomized, double-blind study JO - Ann Intern Med VL - 103 UR - https://doi.org/10.7326/0003-4819-103-4-489 DO - 10.7326/0003-4819-103-4-489 ID - Andersen1985 ER - TY - JOUR AU - van Ede, A. E. AU - Laan, R. F. AU - Blom, H. J. AU - De Abreu, R. A. AU - van de Putte, L. B. PY - 1998 DA - 1998// TI - Methotrexate in rheumatoid arthritis: an update with focus on mechanisms involved in toxicity JO - Semin Arthritis Rheum VL - 27 UR - https://doi.org/10.1016/S0049-0172(98)80049-8 DO - 10.1016/S0049-0172(98)80049-8 ID - van Ede1998 ER - TY - JOUR AU - Cronstein, B. N. PY - 1997 DA - 1997// TI - The mechanism of action of methotrexate JO - Rheum Dis Clin North Am VL - 23 UR - https://doi.org/10.1016/S0889-857X(05)70358-6 DO - 10.1016/S0889-857X(05)70358-6 ID - Cronstein1997 ER - TY - JOUR AU - Swierkot, J. AU - Szechiński, J. PY - 2006 DA - 2006// TI - Methotrexate in rheumatoid arthritis JO - Pharmacol Rep VL - 58 ID - Swierkot2006 ER - TY - JOUR AU - Alarcón, G. S. AU - Tracy, I. C. AU - Blackburn, W. D. PY - 1989 DA - 1989// TI - Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment JO - Arthritis Rheum VL - 32 UR - https://doi.org/10.1002/anr.1780320603 DO - 10.1002/anr.1780320603 ID - Alarcón1989 ER - TY - JOUR AU - Aletaha, D. AU - Smolen, J. S. PY - 2002 DA - 2002// TI - The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses JO - Rheumatology (Oxford) VL - 41 UR - https://doi.org/10.1093/rheumatology/41.12.1367 DO - 10.1093/rheumatology/41.12.1367 ID - Aletaha2002 ER - TY - JOUR AU - Maetzel, A. AU - Wong, A. AU - Strand, V. AU - Tugwell, P. AU - Wells, G. AU - Bombardier, C. PY - 2000 DA - 2000// TI - Meta-analysis of treatment termination rates among rheumatoid arthritis patients receiving disease-modifying anti-rheumatic drugs JO - Rheumatology (Oxford) VL - 39 UR - https://doi.org/10.1093/rheumatology/39.9.975 DO - 10.1093/rheumatology/39.9.975 ID - Maetzel2000 ER - TY - JOUR AU - Goldman, I. D. AU - Lichtenstein, N. S. AU - Oliverio, V. T. PY - 1968 DA - 1968// TI - Carrier-mediated transport of the folic acid analogue, methotrexate, in the L1210 leukemia cell JO - J Biol Chem VL - 243 ID - Goldman1968 ER - TY - JOUR AU - Matherly, L. H. AU - Goldman, D. I. PY - 2003 DA - 2003// TI - Membrane transport of folates JO - Vitam Horm VL - 66 UR - https://doi.org/10.1016/S0083-6729(03)01012-4 DO - 10.1016/S0083-6729(03)01012-4 ID - Matherly2003 ER - TY - JOUR AU - Cronstein, B. N. PY - 1996 DA - 1996// TI - Molecular therapeutics. Methotrexate and its mechanism of action JO - Arthritis Rheum VL - 39 UR - https://doi.org/10.1002/art.1780391203 DO - 10.1002/art.1780391203 ID - Cronstein1996 ER - TY - JOUR AU - Cutolo, M. AU - Sulli, A. AU - Pizzorni, C. AU - Seriolo, B. AU - Straub, R. H. PY - 2001 DA - 2001// TI - Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis JO - Ann Rheum Dis VL - 60 UR - https://doi.org/10.1136/ard.60.8.729 DO - 10.1136/ard.60.8.729 ID - Cutolo2001 ER - TY - JOUR AU - Ranganathan, P. AU - Eisen, S. AU - Yokoyama, W. M. AU - McLeod, H. L. PY - 2003 DA - 2003// TI - Will pharmacogenetics allow better prediction of methotrexate toxicity and efficacy in patients with rheumatoid arthritis? JO - Ann Rheum Dis VL - 62 UR - https://doi.org/10.1136/ard.62.1.4 DO - 10.1136/ard.62.1.4 ID - Ranganathan2003 ER - TY - JOUR AU - Gorlick, R. AU - Cole, P. AU - Banerjee, D. AU - Longo, G. AU - Li, W. W. AU - Hochhauser, D. AU - Bertino, J. R. PY - 1999 DA - 1999// TI - Mechanisms of methotrexate resistance in acute leukemia. Decreased transport and polyglutamylation JO - Adv Exp Med Biol VL - 457 UR - https://doi.org/10.1007/978-1-4615-4811-9_59 DO - 10.1007/978-1-4615-4811-9_59 ID - Gorlick1999 ER - TY - JOUR AU - Wong, S. C. AU - Zhang, L. AU - Witt, T. L. AU - Proefke, S. A. AU - Bhushan, A. AU - Matherly, L. H. PY - 1999 DA - 1999// TI - Impaired membrane transport in methotrexate-resistant CCRF-CEM cells involves early translation termination and increased turnover of a mutant reduced folate carrier JO - J Biol Chem VL - 274 UR - https://doi.org/10.1074/jbc.274.15.10388 DO - 10.1074/jbc.274.15.10388 ID - Wong1999 ER - TY - JOUR AU - Iwanami, K. AU - Matsumoto, I. AU - Tanaka-Watanabe, Y. AU - Inoue, A. AU - Mihara, M. AU - Ohsugi, Y. AU - Mamura, M. AU - Goto, D. AU - Ito, S. AU - Tsutsumi, A. AU - Kishimoto, T. AU - Sumida, T. PY - 2008 DA - 2008// TI - Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase JO - Arthritis Rheum VL - 58 UR - https://doi.org/10.1002/art.23222 DO - 10.1002/art.23222 ID - Iwanami2008 ER - TY - JOUR AU - Taylor, P. C. AU - Williams, R. O. AU - Maini, R. N. PY - 2000 DA - 2000// TI - Anti-TNF alpha therapy in rheumatoid arthritis--current and future directions JO - Curr Dir Autoimmun VL - 2 UR - https://doi.org/10.1159/000060499 DO - 10.1159/000060499 ID - Taylor2000 ER - TY - JOUR AU - Smolen, J. S. AU - Beaulieu, A. AU - Rubbert-Roth, A. AU - Ramos-Remus, C. AU - Rovensky, J. AU - Alecock, E. AU - Woodworth, T. AU - Alten, R. PY - 2008 DA - 2008// TI - Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial JO - Lancet VL - 371 UR - https://doi.org/10.1016/S0140-6736(08)60453-5 DO - 10.1016/S0140-6736(08)60453-5 ID - Smolen2008 ER - TY - JOUR AU - Schiff, M. AU - Pritchard, C. AU - Huffstutter, J. E. AU - Rodriguez-Valverde, V. AU - Durez, P. AU - Zhou, X. AU - Li, T. AU - Bahrt, K. AU - Kelly, S. AU - Le Bars, M. AU - Genovese, M. C. PY - 2009 DA - 2009// TI - The 6-month safety and efficacy of abatacept in patients with rheumatoid arthritis who underwent a washout after anti-tumour necrosis factor therapy or were directly switched to abatacept: the ARRIVE trial JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.099218 DO - 10.1136/ard.2008.099218 ID - Schiff2009 ER - TY - JOUR AU - Matsumoto, I. AU - Zhang, H. AU - Yasukochi, T. AU - Iwanami, K. AU - Tanaka, Y. AU - Inoue, A. AU - Goto, D. AU - Ito, S. AU - Tsutsumi, A. AU - Sumida, T. PY - 2008 DA - 2008// TI - Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis JO - Arthritis Res Ther VL - 10 UR - https://doi.org/10.1186/ar2437 DO - 10.1186/ar2437 ID - Matsumoto2008 ER - TY - JOUR AU - Okazaki, M. AU - Yamada, Y. AU - Nishimoto, N. AU - Yoshizaki, K. AU - Mihara, M. PY - 2002 DA - 2002// TI - Characterization of anti-mouse interleukin-6 receptor antibody JO - Immunol Lett VL - 84 UR - https://doi.org/10.1016/S0165-2478(02)00202-X DO - 10.1016/S0165-2478(02)00202-X ID - Okazaki2002 ER - TY - JOUR AU - Mihara, M. AU - Urakawa, K. AU - Takagi, N. AU - Moriya, Y. AU - Takeda, Y. PY - 1996 DA - 1996// TI - In vitro and in vivo biological activities of a novel nonpolyglutamable anti-folate, MX-68 JO - Immunopharmacology VL - 35 UR - https://doi.org/10.1016/0162-3109(96)00117-8 DO - 10.1016/0162-3109(96)00117-8 ID - Mihara1996 ER - TY - JOUR AU - Hagihara, K. AU - Nishikawa, T. AU - Isobe, T. AU - Song, J. AU - Sugamata, Y. AU - Yoshizaki, K. PY - 2004 DA - 2004// TI - IL-6 plays a critical role in the synergistic induction of human serum amyloid A (SAA) gene when stimulated with proinflammatory cytokines as analyzed with an SAA isoform real-time quantitative RT-PCR assay system JO - Biochem Biophys Res Commun VL - 314 UR - https://doi.org/10.1016/j.bbrc.2003.12.096 DO - 10.1016/j.bbrc.2003.12.096 ID - Hagihara2004 ER - TY - JOUR AU - van der Heijden, J. W. AU - Oerlemans, R. AU - Tak, P. P. AU - Assaraf, Y. G. AU - Kraan, M. C. AU - Scheffer, G. L. AU - van der Laken, C. J. AU - Lems, W. F. AU - Scheper, R. J. AU - Dijkmans, B. A. AU - Jansen, G. PY - 2009 DA - 2009// TI - Involvement of breast cancer resistance protein expression on rheumatoid arthritis synovial tissue macrophages in resistance to methotrexate and leflunomide JO - Arthritis Rheum VL - 60 UR - https://doi.org/10.1002/art.24354 DO - 10.1002/art.24354 ID - van der Heijden2009 ER - TY - JOUR AU - Agarwal, V. AU - Mittal, S. K. AU - Misra, R. PY - 2009 DA - 2009// TI - Expression of multidrug resistance-1 protein correlates with disease activity rather than the refractoriness to methotrexate therapy in rheumatoid arthritis JO - Clin Rheumatol VL - 28 UR - https://doi.org/10.1007/s10067-008-1071-1 DO - 10.1007/s10067-008-1071-1 ID - Agarwal2009 ER - TY - JOUR AU - Baugh, C. M. AU - Krumdieck, C. L. AU - Nair, M. G. PY - 1973 DA - 1973// TI - Polygammaglutamyl metabolites of methotrexate JO - Biochem Biophys Res Commun VL - 52 UR - https://doi.org/10.1016/0006-291X(73)90949-2 DO - 10.1016/0006-291X(73)90949-2 ID - Baugh1973 ER - TY - JOUR AU - Chabner, B. A. AU - Allegra, C. J. AU - Curt, G. A. AU - Clendeninn, N. J. AU - Baram, J. AU - Koizumi, S. AU - Drake, J. C. AU - Jolivet, J. PY - 1985 DA - 1985// TI - Polyglutamation of methotrexate. Is methotrexate a prodrug? JO - J Clin Invest VL - 76 UR - https://doi.org/10.1172/JCI112088 DO - 10.1172/JCI112088 ID - Chabner1985 ER - TY - JOUR AU - Kumar, P. AU - Kisliuk, R. L. AU - Gaumont, Y. AU - Freisheim, J. H. AU - Nair, M. G. PY - 1989 DA - 1989// TI - Inhibition of human dihydrofolate reductase by antifolyl polyglutamates JO - Biochem Pharmacol VL - 38 UR - https://doi.org/10.1016/0006-2952(89)90397-3 DO - 10.1016/0006-2952(89)90397-3 ID - Kumar1989 ER - TY - JOUR AU - Rhee, M. S. AU - Wang, Y. AU - Nair, M. G. AU - Galivan, J. PY - 1993 DA - 1993// TI - Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity JO - Cancer Res VL - 53 ID - Rhee1993 ER - TY - JOUR AU - Hibi, M. AU - Murakami, M. AU - Saito, M. AU - Hirano, T. AU - Taga, T. AU - Kishimoto, T. PY - 1990 DA - 1990// TI - Molecular cloning and expression of an IL-6 signal transducer, gp130 JO - Cell VL - 63 UR - https://doi.org/10.1016/0092-8674(90)90411-7 DO - 10.1016/0092-8674(90)90411-7 ID - Hibi1990 ER - TY - JOUR AU - Kotake, S. AU - Sato, K. AU - Kim, K. J. AU - Takahashi, N. AU - Udagawa, N. AU - Nakamura, I. AU - Yamaguchi, A. AU - Kishimoto, T. AU - Suda, T. AU - Kashiwazaki, S. PY - 1996 DA - 1996// TI - Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation JO - J Bone Miner Res VL - 11 UR - https://doi.org/10.1002/jbmr.5650110113 DO - 10.1002/jbmr.5650110113 ID - Kotake1996 ER - TY - JOUR AU - Takeuchi, T. AU - Tanaka, Y. AU - Amano, K. AU - Hoshi, D. AU - Nawata, M. AU - Nagasawa, H. AU - Sato, E. AU - Saito, K. AU - Kaneko, Y. AU - Fukuyo, S. AU - Kurasawa, T. AU - Hanami, K. AU - Kameda, H. AU - Yamanaka, H. PY - 2011 DA - 2011// TI - Clinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study JO - Rheumatology (Oxford) VL - 50 UR - https://doi.org/10.1093/rheumatology/ker221 DO - 10.1093/rheumatology/ker221 ID - Takeuchi2011 ER - TY - JOUR AU - Uchiyama, Y. AU - Yoshida, H. AU - Koike, N. AU - Hayakawa, N. AU - Sugita, A. AU - Nishimura, T. AU - Mihara, M. PY - 2008 DA - 2008// TI - Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production JO - Int Immunopharmacol VL - 8 UR - https://doi.org/10.1016/j.intimp.2008.07.002 DO - 10.1016/j.intimp.2008.07.002 ID - Uchiyama2008 ER - TY - JOUR AU - Salliot, C. AU - Finckh, A. AU - Katchamart, W. AU - Lu, Y. AU - Sun, Y. AU - Bombardier, C. AU - Keystone, E. PY - 2011 DA - 2011// TI - Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis JO - Ann Rheum Dis VL - 70 UR - https://doi.org/10.1136/ard.2010.132134 DO - 10.1136/ard.2010.132134 ID - Salliot2011 ER - TY - JOUR AU - Bendtzen, K. AU - Geborek, P. AU - Svenson, M. AU - Larsson, L. AU - Kapetanovic, M. C. AU - Saxne, T. PY - 2006 DA - 2006// TI - Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.22214 DO - 10.1002/art.22214 ID - Bendtzen2006 ER - TY - JOUR AU - Radstake, T. R. AU - Svenson, M. AU - Eijsbouts, A. M. AU - van den Hoogen, F. H. AU - Enevold, C. AU - van Riel, P. L. AU - Bendtzen, K. PY - 2009 DA - 2009// TI - Formation of antibodies against infliximab and adalimumab strongly correlates with functional drug levels and clinical responses in rheumatoid arthritis JO - Ann Rheum Dis VL - 68 UR - https://doi.org/10.1136/ard.2008.092833 DO - 10.1136/ard.2008.092833 ID - Radstake2009 ER - TY - JOUR AU - Wolbink, G. J. AU - Vis, M. AU - Lems, W. AU - Voskuyl, A. E. AU - de Groot, E. AU - Nurmohamed, M. T. AU - Stapel, S. AU - Tak, P. P. AU - Aarden, L. AU - Dijkmans, B. PY - 2006 DA - 2006// TI - Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis JO - Arthritis Rheum VL - 54 UR - https://doi.org/10.1002/art.21671 DO - 10.1002/art.21671 ID - Wolbink2006 ER - TY - JOUR AU - Bartelds, G. M. AU - Wijbrandts, C. A. AU - Nurmohamed, M. T. AU - Stapel, S. AU - Lems, W. F. AU - Aarden, L. AU - Dijkmans, B. A. AU - Tak, P. P. AU - Wolbink, G. J. PY - 2007 DA - 2007// TI - Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis JO - Ann Rheum Dis VL - 66 UR - https://doi.org/10.1136/ard.2006.065615 DO - 10.1136/ard.2006.065615 ID - Bartelds2007 ER - TY - JOUR AU - van Riel, P. L. AU - Taggart, A. J. AU - Sany, J. AU - Gaubitz, M. AU - Nab, H. W. AU - Pedersen, R. AU - Freundlich, B. AU - MacPeek, D. PY - 2006 DA - 2006// TI - Efficacy and safety of combination etanercept and methotrexate versus etanercept alone in patients with rheumatoid arthritis with an inadequate response to methotrexate: the ADORE study JO - Ann Rheum Dis VL - 65 UR - https://doi.org/10.1136/ard.2005.043299 DO - 10.1136/ard.2005.043299 ID - van Riel2006 ER - TY - JOUR AU - Kameda, H. AU - Kanbe, K. AU - Sato, E. AU - Ueki, Y. AU - Saito, K. AU - Nagaoka, S. AU - Hidaka, T. AU - Atsumi, T. AU - Tsukano, M. AU - Kasama, T. AU - Shiozawa, S. AU - Tanaka, Y. AU - Yamanaka, H. AU - Takeuchi, T. PY - 2011 DA - 2011// TI - Continuation of methotrexate resulted in better clinical and radiographic outcomes than discontinuation upon starting etanercept in patients with rheumatoid arthritis: 52-week results from the JESMR Study JO - J Rheumatol VL - 38 UR - https://doi.org/10.3899/jrheum.110014 DO - 10.3899/jrheum.110014 ID - Kameda2011 ER - TY - JOUR AU - Popa, C. AU - Netea, M. G. AU - Radstake, T. AU - Van der Meer, J. W. AU - Stalenhoef, A. F. AU - van Riel, P. L. AU - Barerra, P. PY - 2005 DA - 2005// TI - Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis JO - Ann Rheum Dis VL - 64 UR - https://doi.org/10.1136/ard.2004.023119 DO - 10.1136/ard.2004.023119 ID - Popa2005 ER -